These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3793264)

  • 1. Vitamin-K-dependent proteins in microsomes of primary Lewis lung tumors.
    Wilson AC; Fasco MJ
    Int J Cancer; 1986 Dec; 38(6):877-82. PubMed ID: 3793264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
    Lee JJ; Principe LM; Fasco MJ
    Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
    Fasco MJ; Hildebrandt EF; Suttie JW
    J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
    Hazelett SE; Preusch PC
    Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH; Baars LG
    Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
    Thijssen HH; Baars LG; Vervoort-Peters HT
    Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ; Principe LM; Walsh WA; Friedman PA
    Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of S-warfarin administration on vitamin K 2,3-epoxide reductase activity in liver, kidney and testis of the rat.
    Thijssen HH; Janssen CA; Drittij-Reijnders MJ
    Biochem Pharmacol; 1986 Oct; 35(19):3277-82. PubMed ID: 3768021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
    Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
    Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ; Principe LM
    J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
    Mukharji I; Silverman RB
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells.
    Fasco MJ; Wilson AC; Lincoln D; Gierthy J
    Int J Cancer; 1987 May; 39(5):631-7. PubMed ID: 3570555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
    Uitendaal MP; Thijssen HH; Drittij-Reijnders MJ; Hoeijmakers MJ
    Biochem Biophys Res Commun; 1986 Jun; 137(3):1015-20. PubMed ID: 3729947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
    Thijssen HH
    Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
    Thijssen HH; Drittij-Reijnders MJ
    Br J Haematol; 1993 Aug; 84(4):681-5. PubMed ID: 8217828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
    Cain D; Hutson SM; Wallin R
    J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
    Thijssen HH; Janssen YP; Vervoort LT
    Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation.
    Vervoort LM; Ronden JE; Thijssen HH
    Biochem Pharmacol; 1997 Oct; 54(8):871-6. PubMed ID: 9354587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of vitamin K and vitamin K 2,3-epoxide via interaction with a common disulfide.
    Lee JJ; Fasco MJ
    Biochemistry; 1984 May; 23(10):2246-52. PubMed ID: 6733086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.